WASHINGTON — A more modest cancer moonshot?
Not so fast, says Eric Lander. The White House science adviser pushed back on the many characterizations of the new effort as smaller and less ambitious than the 2016 push, in an interview with STAT this week.
About the Author Reprints
Create a display name to comment
This name will appear with your comment
